We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Eye Care

Journal Scan / Research · July 16, 2021

Effects of HtrA1 Inhibition in Geographic Atrophy Secondary to AMD

American Journal of Ophthalmology

 

Additional Info

American Journal of Ophthalmology
Phase I Study of the Anti-HtrA1 Antibody-Binding Fragment FHTR2163 in Geographic Atrophy Secondary to Age-Related Macular Degeneration
Am J Ophthalmol 2021 Jun 29;[EPub Ahead of Print], AM Khanani, VS Hershberger, DJ Pieramici, RN Khurana, F Brunstein, L Ma, KF Maass, LA Honigberg, I Tom, H Chen, EC Strauss, P Lai

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading